December 8, 2022
UNC Health is leading the way in glioblastoma treatment with a new clinical trial. The study will evaluate the safety and tolerability of CAR-T immunotherapy in patients with recurrent or progressive glioblastoma.
November 21, 2022
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.
September 12, 2022
The article by Marc Bjurlin, DO, associate professor of urology, is one of a series of publications that is originating from new collaborations between UNC'S Department of Urology and the UNC Tobacco Treatment Program.
August 23, 2022
Experiments from the UNC School of Medicine lab of Nobel Prize-winning scientist Aziz Sancar, MD, PhD, show how a common molecular tool for DNA labeling also has anticancer properties worthy of further investigation, especially for brain cancers.
July 21, 2022
Chad Pecot, MD, associate professor of medicine and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of RNA in health and disease.
May 4, 2022
UNC Children's renamed its hematology/oncology clinic The Reelin' for Research Pediatric Hematology Oncology Clinic in honor of the organization that donated $800,000 this week and more than $5 million since 2009, all to fund cancer research at UNC Children's.
May 3, 2022
Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics, and Ralph Baric, PhD, the William Kenan Distinguished Professor of Epidemiology and Microbiology & Immunology, were elected as members of the American Academy of Arts & Sciences.
April 19, 2022
This virtual seminar series will provide a background in the use of machine learning tools to answer clinical questions, understand the strengths and limitations of these methods, and examine real-world examples of machine learning methodology in clinical research. The series is co-sponsored by the UNC Core Center for Clinical Research and the UNC Program for Precision Medicine in Health Care.
April 11, 2022
Sarah Kowitt, PhD, MPH, Adam Goldstein, MD, MPH, and Samuel Cykert, MD, recently published a study that found a cardiovascular disease risk reduction intervention improved rates of tobacco screening and cessation support in small primary care practices in North Carolina.
March 24, 2022
Researchers led by Yevgeny Brudno, PhD, in the UNC-NCSU Joint Biomedical Engineering Department, have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.
March 8, 2022
UNC Health will partner with Philips to implement evidence-based treatment paths using Philips Oncology Pathways software, a new clinical tool to help doctors match patients with the best possible chemotherapy regimen for their condition. The clinical content will be routinely refreshed in partnership with Harvard Medical School’s Dana-Farber Cancer Institute and other leading cancer centers across the country.
March 1, 2022
The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.